This innovative treatment has captured the attention of both healthcare providers and patients alike for its role in addressing weight loss and obesity-related conditions
Just like Ozempic, Wegovy is given as a subcutaneous injection once a week, under the skin of the stomach, thigh, or upper arm
The US GLP-1 user population is large and growing, and current government policy and drug-provider pricing strategies are breaking down adoption barriers and may make it grow faster, said Rick Miller, partner and marketing effectiveness practice lead at Big Chalk
Neuroprotection remains a formidable challenge, as every central nervous system (CNS) insult, be it stroke, trauma, or neurodegenerative disease, activates multiple, overlapping injury pathways
Our medical weight loss program can help you reach your health goals
While this is exactly what the medication is supposed to do, it can feel strange when youre not naturally motivated to consume adequate nutrition